Dynavax Technologies Corporation

Dynavax Technologies Corporation - PE Ratioverified

DVAX

Price:

$15.5

Market Cap:

$1.82B

Dynavax Technologies Corporation is a biopharmaceutical firm specializing in the development and market introduction of innovative vaccines, primarily operating in the United States. The company's lead product is HEPLISAV-B, a vaccine approved for adults 18 years and older in the U.S. and Europe, which offers protection against all identified subtypes of the hepatitis B virus. Additionally, Dynavax produces and distributes CpG 1018, the specific adjuvant ingredient used in HEPLISAV-B. Dynavax maintains several strategic alliances, including a collaboration agreement with Valneva Scotland Limited, an agreement with Serum Institute of India Pvt. Ltd., and a sublicense agreement with Merck, Sha...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2004-02-19

Stock Exchange

NASDAQ

Ticker

DVAX

The PE Ratio as of June 2026 (TTM) for Dynavax Technologies Corporation (DVAX) is -41.89

According to Dynavax Technologies Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -41.89. This represents a change of -309.40% compared to the average of 20.01 of the last 4 quarters.

Dynavax Technologies Corporation (DVAX) Historical PE Ratio (quarterly & annually)

How has DVAX PE Ratio performed in the past?

The mean historical PE Ratio of Dynavax Technologies Corporation over the last ten years is -22.51. The current -41.89 PE Ratio has changed 18.51% with respect to the historical average. Over the past ten years (40 quarters), DVAX's PE Ratio was at its highest in in the December 2023 quarter at 2.06K. The PE Ratio was at its lowest in in the March 2024 quarter at -46.94.

Quarterly (TTM)
Annual

Average

-22.51

Median

-3.16

Minimum

-281.85

Maximum

60.81

Dynavax Technologies Corporation (DVAX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Dynavax Technologies Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 663.75%

Maximum Annual PE Ratio = 60.81

Minimum Annual Increase = -6245.71%

Minimum Annual PE Ratio = -281.85

Quarterly (TTM)
Annual
YearPE RatioChange
202460.81-121.57%
2023-281.85-6245.71%
20224.59-79.79%
202122.69-482.48%
2020-5.93117.83%
2019-2.72-24.09%
2018-3.59-65.27%
2017-10.33663.75%
2016-1.35-81.80%
2015-7.4352.12%

Dynavax Technologies Corporation (DVAX) Average PE Ratio

How has DVAX PE Ratio performed in the past?

The current PE Ratio of Dynavax Technologies Corporation (DVAX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-72.15

5-year avg

-39.94

10-year avg

-22.51

Dynavax Technologies Corporation (DVAX) PE Ratio vs. Peers

How is DVAX’s PE Ratio compared to its peers?

Dynavax Technologies Corporation’s PE Ratio is less than Amphastar Pharmaceuticals, Inc. (11.00), less than Collegium Pharmaceutical, Inc. (14.15), less than Beta Bionics, Inc. (-9.19), less than Pacira BioSciences, Inc. (182.88), less than Immatics N.V. (-4.98), less than Evotec SE (-4.26), greater than STAAR Surgical Company (-69.33), less than Enliven Therapeutics, Inc. (-27.50), less than Pulse Biosciences, Inc. (-23.49), greater than Harrow Health, Inc. (-109.22),

Build a custom stock screener for Dynavax Technologies Corporation (DVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dynavax Technologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dynavax Technologies Corporation (DVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dynavax Technologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Dynavax Technologies Corporation's PE Ratio?

How is the PE Ratio calculated for Dynavax Technologies Corporation (DVAX)?

What is the highest PE Ratio for Dynavax Technologies Corporation (DVAX)?

What is the 3-year average PE Ratio for Dynavax Technologies Corporation (DVAX)?

What is the 5-year average PE Ratio for Dynavax Technologies Corporation (DVAX)?

How does the current PE Ratio for Dynavax Technologies Corporation (DVAX) compare to its historical average?